Skip to content

Onco-Respirology Epidemiology Based on Real-world Big Data in Respiratory Medicine

Onco-Respirology Epidemiology Based on Real-world Big Data in Respiratory Medicine

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06670560
Enrollment
100000
Registered
2024-11-01
Start date
2024-09-05
Completion date
2026-06-30
Last updated
2024-11-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Epidemiology, Neoplasms, Respiratory

Brief summary

The purpose of this observational study is to understand the changes in the types of respiratory patients hospitalized in China in recent years through a multicenter retrospective clinical study, and at the same time to understand the reasons for hospitalization and the distribution of different tumor types in oncology patients, so as to provide data support and theoretical basis for the future development of China's respiratory department. The main questions it aims to answer are 1. the trend of change of respiratory diseases in China in the past 10 years. 2. the trend of change in the causes of hospitalization of respiratory tumor patients in China in the past 10 years. 3. the trend of the proportion of each tumor in the respiratory department in China over the past 10 years.

Interventions

None listed

Sponsors

Zhou Chengzhi
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

Clinical diagnosis of Respiratory diseases Must be an inpatient

Exclusion criteria

Non-respiratory inpatients

Design outcomes

Primary

MeasureTime frameDescription
proportion10 years1. to explore the trend of respiratory diseases (COPD, asthma, bronchiectasis, lung infection, lung cancer, etc.) over the past 10 years in China. 2. to explore the trend of the causes of hospitalization of respiratory tumor patients (pulmonary embolism, airway stenosis, post-surgical complications, lung infection, pneumothorax, tuberculosis, etc.) in China over the past 10 years. 3. to explore the trend of the proportion of each tumor in the respiratory department (brain tumor, nasopharyngeal cancer, thyroid cancer, lung cancer, breast cancer, liver cancer, etc.) over the past 10 years in China.

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026